Semaglutide Storage & Stability: Compounding Pharmacy Guidelines

Last reviewed: May 26, 2026

Last updated: May 26, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Semaglutide remains stable for specific periods depending on storage conditions, formulation, and whether it has been opened. Unopened vials refrigerated at 2–8°C maintain full potency until the expiration date printed on the label, typically 2–3 years from manufacturing. After opening or beginning use, stability windows narrow significantly, requiring careful temperature control and timely use.

For patients using compounded semaglutide from licensed 503A pharmacies, understanding stability is critical for treatment efficacy and safety. Proper storage protects the medication's molecular integrity and ensures consistent dosing. PlexusDx emphasizes that patients should always follow pharmacy-specific storage instructions and discuss any concerns about medication handling with their healthcare provider.

Temperature Control and Refrigeration Requirements

Semaglutide requires consistent refrigeration at 2–8°C (36–46°F) before first use to maintain stability. Exposure to temperatures above 8°C accelerates molecular degradation, reducing potency and potentially compromising therapeutic effect. A standard refrigerator maintains this range reliably; freezing semaglutide is not recommended and may damage the formulation.

Once you begin using semaglutide, some formulations may be stored at room temperature (up to 25°C/77°F) for limited periods. The exact duration depends on the specific compounded product and manufacturer instructions. Check your pharmacy's guidance on your medication label, as storage protocols vary between 503A compounding facilities and branded formulations.

Storage Stability Timeline and Expiration Protocols

Semaglutide stability varies by formulation stage and storage method. Below is a framework for understanding typical stability windows across common scenarios encountered in compounded preparations and clinical use.

Storage Scenario	Temperature Range	Expected Stability	Key Consideration
Unopened vial, refrigerated	2–8°C (36–46°F)	2–3 years from manufacturing	Check printed expiration date on label
Opened vial, refrigerated	2–8°C (36–46°F)	28 days typical	Mark opening date; discard after window
Opened vial, room temperature	Up to 25°C (77°F)	Up to 30 days (varies by compound)	Verify with pharmacy; do not exceed
Exposed to freezing or heat	Below 2°C or above 30°C	Compromised; discard immediately	Do not use; contact pharmacy for replacement

Light Exposure and Environmental Factors Affecting Potency

Light exposure degrades semaglutide's chemical structure, particularly ultraviolet (UV) radiation. Store vials in original packaging or opaque containers away from direct sunlight and fluorescent lighting. Bathroom medicine cabinets near shower steam or kitchen cabinets near heat sources accelerate degradation and should be avoided.

Environmental humidity and air exposure can also compromise stability. Keep vials tightly capped when not in use, and avoid opening containers unnecessarily. If you travel, use an insulated cooling case to maintain temperature stability. These practices protect the medication's integrity and ensure each dose delivers intended efficacy.

Safety Considerations and When to Discard or Replace

Discard semaglutide immediately if it appears cloudy, discolored, contains particles, or has exceeded its stability window. Visual inspection before each injection is a critical safety step. Never use a vial after the expiration date printed on the label, even if it appears normal, as molecular potency may be compromised below therapeutic levels.

If semaglutide is accidentally exposed to freezing, extreme heat, or sunlight, contact your compounding pharmacy before using it. Many 503A pharmacies offer replacement protocols for damaged medication. Your provider can also help determine if a dose adjustment or restart is appropriate if you suspect compromised medication has been used.

How PlexusDx Supports a More Personalized Approach

PlexusDx compounded semaglutide is prepared by licensed 503A compounding pharmacies, which are held to rigorous stability and quality standards. Understanding how storage and stability relate to your individual response to semaglutide may help provide context for treatment personalization conversations with your provider. Genetic factors influencing GLP-1 receptor sensitivity can mean that medication potency and consistency are especially important for optimal outcomes.

The Precision Peptide Genetic Test from PlexusDx examines variants in GLP1R (rs6923761) and other peptide pathway genes that may predispose individuals to variable responses to GLP-1 medications. While the test does not predict exact medication response, it can support a more informed dialogue with your healthcare provider about treatment expectations and dosing strategy. Combined with proper storage practices, this personalized context may enhance treatment planning.

If you are considering compounded semaglutide from PlexusDx, discussing both medication storage best practices and any relevant genetic or biomarker insights with your qualified healthcare provider strengthens the foundation for safe, effective treatment. Your provider can integrate stability protocols, storage guidance from your 503A pharmacy, and personalized medical history into a comprehensive treatment plan tailored to your needs.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Oral starts at from $209/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.